8Stal P, Lindberg G, Ost A, Iwarzon M, Seensalu R. Gastroesop- hageal reflux in healthy subjects. Significance of endosco-pic findings, Histology, Age and Sex[J]. Scand J Gastroentrol, 1999,34: 121-128
9Schnatz PF, Castell JA, Castell DO. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy[J]. Am J Gastroenterol, 1996.91 : 1715
4Buffoni L,Dongiovanni D,Barone C,et al.Fractionated dose of cisplant (CDDP)and vinorelbine (VNB)chemotherapy for elderly patients with advanced non-small cell lung cancer phaseⅡtrial. Lung Cancer . 2006
5Chung IK, Lee DH, Kim HU, et al. Guidelines of treatment for bleeding peptic ulcer disease. Korean J Gastroenterol, 2009, 54: 298-305.
6Tsibouris P, Zintzaras E, Lappas C, et al. High-dose pantoprazole continuous infusion is superior to soma- tostatin after endoscopic hemostasis in patients with pep- tic ulcer bleeding. Am J Gastroenterol, 2007, 102 : 1192-1199.
7Mostaghni AA, Hashemi SA, Heydari ST. Comparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial. Iran Red Crescent MedJ, 2011, 13: 458-463.
9Miner PJ, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, panto- prazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol, 2003, 98: 2616-2620.
10Wedemeyer RS, Blume H. Pharmacokinetie drug inter- action profiles of proton pump inhibitors: an update. Drug Saf, 2014, 37: 201-211.
